Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy

Clinical data suggest that only a subgroup of non-small cell lung cancer (NSCLC) patients has long-term benefits after front-line platinum-based therapy. We prospectively investigate whether KRAS status and DNA polymerase β expression could help identify patients responding to platinum compounds. Pr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Alvisi, Maria Francesca, Ganzinelli, Monica, Linardou, Helena, Caiola, Elisa, Lo Russo, Giuseppe, Cecere, Fabiana Letizia, Bettini, Anna Cecilia, Psyrri, Amanda, Milella, Michele, Rulli, Eliana, Fabbri, Alessandra, De Maglie, Marcella, Romanelli, Pierpaolo, Murray, Samuel, Ndembe, Gloriana, Broggini, Massimo, Garassino, Marina Chiara, Marabese, Mirko
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7465625/
https://ncbi.nlm.nih.gov/pubmed/32751518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082438
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky